JP2020183414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020183414A5 JP2020183414A5 JP2020120896A JP2020120896A JP2020183414A5 JP 2020183414 A5 JP2020183414 A5 JP 2020183414A5 JP 2020120896 A JP2020120896 A JP 2020120896A JP 2020120896 A JP2020120896 A JP 2020120896A JP 2020183414 A5 JP2020183414 A5 JP 2020183414A5
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- phosphoramidate
- base
- contacting
- isolating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 claims 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 4
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 239000011541 reaction mixture Substances 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 2
- -1 nucleoside phosphoramidate Chemical class 0.000 claims 2
- 230000003287 optical Effects 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- QLKNFSOWJQLKLV-UHFFFAOYSA-N 2-amino-4-methylpentan-3-ol Chemical compound CC(C)C(O)C(C)N QLKNFSOWJQLKLV-UHFFFAOYSA-N 0.000 claims 1
- BOFRXDMCQRTGII-UHFFFAOYSA-N 619-08-9 Chemical compound OC1=CC=C([N+]([O-])=O)C=C1Cl BOFRXDMCQRTGII-UHFFFAOYSA-N 0.000 claims 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N N,N-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- TXFOLHZMICYNRM-UHFFFAOYSA-N dichlorophosphoryloxybenzene Chemical compound ClP(Cl)(=O)OC1=CC=CC=C1 TXFOLHZMICYNRM-UHFFFAOYSA-N 0.000 claims 1
- 239000008079 hexane Substances 0.000 claims 1
- CQRPUKWAZPZXTO-UHFFFAOYSA-M magnesium;2-methylpropane;chloride Chemical group [Mg+2].[Cl-].C[C-](C)C CQRPUKWAZPZXTO-UHFFFAOYSA-M 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 230000001376 precipitating Effects 0.000 claims 1
- QDQVXVRZVCTVHE-YFKPBYRVSA-N propan-2-yl (2S)-2-aminopropanoate Chemical group CC(C)OC(=O)[C@H](C)N QDQVXVRZVCTVHE-YFKPBYRVSA-N 0.000 claims 1
- QDQVXVRZVCTVHE-UHFFFAOYSA-N propan-2-yl 2-aminopropanoate Chemical compound CC(C)OC(=O)C(C)N QDQVXVRZVCTVHE-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
Claims (13)
- 前記塩基が塩化tert−ブチルマグネシウムである、請求項1に記載の方法。
- 前記ホスホルアミデートが、以下:
イソプロピル2−アミノプロパノエート、フェニルジクロロホスフェートおよび第2の塩基を接触させて、混合物を提供する工程、
前記混合物と、ペンタフルオロフェノールまたは2−クロロ−4−ニトロフェノールとを接触させて、ホスホルアミデートの混合物を提供する工程
によって調製される、請求項1に記載の方法。 - 前記混合物から前記ホスホルアミデートの光学異性体を沈殿させる工程をさらに含む、請求項4に記載の方法。
- 前記第2の塩基がトリエチルアミンである、請求項4に記載の方法。
- 前記イソプロピル2−アミノプロパノエートが、(S)−イソプロピル2−アミノプロパノエートである、請求項4に記載の方法。
- 前記塩基がトリエチルアミンである、請求項9に記載の方法。
- 前記反応混合物および前記生成混合物が、溶媒ジクロロメタンをさらに含む、請求項9に記載の方法。
- 前記ジアステレオマー混合物を単離する工程が、前記生成物から固体を濾過する工程を含む、請求項9に記載の方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022039571A JP2022088451A (ja) | 2014-12-15 | 2022-03-14 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462091686P | 2014-12-15 | 2014-12-15 | |
US62/091,686 | 2014-12-15 | ||
US201462094117P | 2014-12-19 | 2014-12-19 | |
US62/094,117 | 2014-12-19 | ||
US201562201974P | 2015-08-06 | 2015-08-06 | |
US62/201,974 | 2015-08-06 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532167A Division JP6735751B2 (ja) | 2014-12-15 | 2015-12-07 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022039571A Division JP2022088451A (ja) | 2014-12-15 | 2022-03-14 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2020183414A JP2020183414A (ja) | 2020-11-12 |
JP2020183414A5 true JP2020183414A5 (ja) | 2020-12-24 |
JP7046388B2 JP7046388B2 (ja) | 2022-04-04 |
Family
ID=56127817
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532167A Active JP6735751B2 (ja) | 2014-12-15 | 2015-12-07 | B型肝炎ウイルスの治療のためのホスホルアミデート |
JP2020120896A Active JP7046388B2 (ja) | 2014-12-15 | 2020-07-14 | B型肝炎ウイルスの治療のためのホスホルアミデート |
JP2022039571A Withdrawn JP2022088451A (ja) | 2014-12-15 | 2022-03-14 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532167A Active JP6735751B2 (ja) | 2014-12-15 | 2015-12-07 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022039571A Withdrawn JP2022088451A (ja) | 2014-12-15 | 2022-03-14 | B型肝炎ウイルスの治療のためのホスホルアミデート |
Country Status (14)
Country | Link |
---|---|
US (3) | US10683319B2 (ja) |
EP (1) | EP3233878A4 (ja) |
JP (3) | JP6735751B2 (ja) |
KR (1) | KR20170110591A (ja) |
CN (1) | CN107428792B (ja) |
AU (2) | AU2015363042B2 (ja) |
BR (1) | BR112017012859A2 (ja) |
CA (1) | CA2969372C (ja) |
HK (1) | HK1244812A1 (ja) |
IL (2) | IL280459B2 (ja) |
PH (1) | PH12017550022A1 (ja) |
SG (2) | SG11201704785RA (ja) |
WO (1) | WO2016099982A2 (ja) |
ZA (2) | ZA201704104B (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3043803B1 (en) | 2013-09-11 | 2022-04-27 | Emory University | Nucleotide and nucleoside compositions and their uses |
EP3203995A4 (en) | 2014-10-09 | 2019-05-15 | Board of Regents of the University of Nebraska | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS |
CA2969372C (en) | 2014-12-15 | 2023-05-16 | Emory University | Phosphoramidates for the treatment of hepatitis b virus |
CA3029315A1 (en) * | 2016-06-24 | 2017-12-28 | Emory University | Phosphoramidates for the treatment of hepatitis b virus |
KR102493872B1 (ko) | 2016-09-02 | 2023-01-30 | 다이서나 파마수이티컬, 인크. | 4'-포스페이트 유사체 및 이를 포함하는 올리고뉴클레오타이드 |
WO2019105404A1 (zh) * | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
CA3083968C (en) | 2017-12-01 | 2024-04-23 | Suzhou Ribo Life Science Co., Ltd. | Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof |
WO2019105419A1 (zh) | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
GB201720279D0 (en) * | 2017-12-05 | 2018-01-17 | Nucana Biomed Ltd | Anticancer compounds |
US11633482B2 (en) | 2017-12-29 | 2023-04-25 | Suzhou Ribo Life Science Co., Ltd. | Conjugates and preparation and use thereof |
EP3737359A4 (en) * | 2018-01-12 | 2021-11-03 | Board of Regents of the University of Nebraska | ANTIVIRAL PRODRUGS AND THEIR FORMULATIONS |
CA3132832A1 (en) | 2018-04-09 | 2019-10-17 | Howard E. Gendelman | Antiviral prodrugs and formulations thereof |
WO2020038377A1 (zh) | 2018-08-21 | 2020-02-27 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的药物组合物和缀合物及其用途 |
JP7376952B2 (ja) | 2018-09-30 | 2023-11-09 | スーチョウ リボ ライフ サイエンス カンパニー、リミテッド | siRNA複合体及びその調製方法と使用 |
GB201904544D0 (en) * | 2019-04-01 | 2019-05-15 | NuCana plc | Anticancer compounds |
WO2021005912A1 (ja) | 2019-07-08 | 2021-01-14 | 日本ポリテック株式会社 | ポリウレタン及び硬化性組成物 |
JPWO2021005914A1 (ja) | 2019-07-08 | 2021-01-14 | ||
WO2022089612A1 (zh) * | 2020-10-30 | 2022-05-05 | 上海岸阔医药科技有限公司 | 尿苷衍生物在制备药物中的应用 |
WO2022251594A1 (en) * | 2021-05-27 | 2022-12-01 | Antios Therapeutics, Inc. | Pharmacokinetics and dose-related improvments in subjects treated with phosphoramidate clevudine prodrugs |
WO2022256490A2 (en) * | 2021-06-03 | 2022-12-08 | Antios Therapeutics, Inc. | Improved synthesis of phosphoramidates for the treatment of hepatitis b virus |
WO2022261046A1 (en) * | 2021-06-07 | 2022-12-15 | Antios Therapeutics, Inc. | Compositions and methods of treating hepatitis d and hepatitis b/hepatitis d co-infections with phosphoramidate clevudine prodrugs |
CN113461760B (zh) * | 2021-09-06 | 2021-12-10 | 南京颐媛生物医学研究院有限公司 | 4-硫代脱氧胸苷衍生物及其抗乙肝病毒制药应用 |
CN114524847B (zh) * | 2021-09-13 | 2023-06-20 | 南京颐媛生物医学研究院有限公司 | 抗乙型肝炎病毒的化合物及其制备方法和应用 |
CN115260263A (zh) * | 2022-05-23 | 2022-11-01 | 深圳扬厉医药技术有限公司 | 烷基硫芳基克拉夫定磷酰胺类化合物及其应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3687931A (en) * | 1970-03-19 | 1972-08-29 | Syntex Corp | Halogenated purine and pyrimidine nucleosides and process therefor |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US7462605B2 (en) | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
MY164523A (en) * | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
US20040229839A1 (en) * | 2003-05-14 | 2004-11-18 | Biocryst Pharmaceuticals, Inc. | Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
EP1827460A4 (en) | 2004-12-09 | 2012-03-14 | Univ Minnesota | NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT |
CN103735560A (zh) | 2005-06-07 | 2014-04-23 | 耶鲁大学 | 使用克来夫定和替比夫定治疗癌症和其它病症或疾病状态的方法 |
US7888330B2 (en) | 2005-11-09 | 2011-02-15 | Wayne State University | Phosphoramidate derivatives of FAU |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
PT2280973E (pt) * | 2008-04-23 | 2013-02-04 | Gilead Sciences Inc | Análogos de carba-nucleósido para tratamento antiviral |
BR112012024884A2 (pt) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | síntese estereosseletiva de ativos contendo fósforo |
PE20140608A1 (es) | 2010-09-22 | 2014-06-12 | Alios Biopharma Inc | Analogos de nucleotidos sustituidos |
US20120142627A1 (en) | 2010-12-06 | 2012-06-07 | Emory University | Monophosphate prodrugs of dapd and analogs thereof |
WO2013013009A2 (en) | 2011-07-19 | 2013-01-24 | Nanjing Molecular Research, Inc. | 2',3'-DIDEOXY-2'-α-FLUORO-2'-β-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF |
WO2013115916A1 (en) | 2012-02-03 | 2013-08-08 | Gilead Sciences, Inc. | Combination therapy comprising gs-7340 and cobicistat for use in the treatment of viral infections |
US9809616B2 (en) | 2012-10-29 | 2017-11-07 | Emory University | Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer |
US20140140951A1 (en) * | 2012-11-14 | 2014-05-22 | Idenix Pharmaceuticals, Inc. | D-Alanine Ester of Rp-Nucleoside Analog |
WO2014160484A1 (en) | 2013-03-13 | 2014-10-02 | Idenix Pharmaceuticals, Inc. | Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv |
CN105377868A (zh) | 2013-04-12 | 2016-03-02 | 艾其林医药公司 | 用于治疗hcv的高活性核苷衍生物 |
EP3004130B1 (en) * | 2013-06-05 | 2019-08-07 | Idenix Pharmaceuticals LLC. | 1',4'-thio nucleosides for the treatment of hcv |
EP3043803B1 (en) | 2013-09-11 | 2022-04-27 | Emory University | Nucleotide and nucleoside compositions and their uses |
CA2969372C (en) | 2014-12-15 | 2023-05-16 | Emory University | Phosphoramidates for the treatment of hepatitis b virus |
-
2015
- 2015-12-07 CA CA2969372A patent/CA2969372C/en active Active
- 2015-12-07 SG SG11201704785RA patent/SG11201704785RA/en unknown
- 2015-12-07 EP EP15870694.5A patent/EP3233878A4/en active Pending
- 2015-12-07 KR KR1020177019279A patent/KR20170110591A/ko not_active Application Discontinuation
- 2015-12-07 US US15/536,237 patent/US10683319B2/en active Active
- 2015-12-07 AU AU2015363042A patent/AU2015363042B2/en active Active
- 2015-12-07 CN CN201580068583.4A patent/CN107428792B/zh active Active
- 2015-12-07 BR BR112017012859A patent/BR112017012859A2/pt not_active Application Discontinuation
- 2015-12-07 IL IL280459A patent/IL280459B2/en unknown
- 2015-12-07 WO PCT/US2015/064338 patent/WO2016099982A2/en active Application Filing
- 2015-12-07 SG SG10202013032YA patent/SG10202013032YA/en unknown
- 2015-12-07 JP JP2017532167A patent/JP6735751B2/ja active Active
-
2017
- 2017-05-31 PH PH12017550022A patent/PH12017550022A1/en unknown
- 2017-06-12 IL IL252842A patent/IL252842B/en active IP Right Grant
- 2017-06-15 ZA ZA2017/04104A patent/ZA201704104B/en unknown
-
2018
- 2018-03-23 HK HK18104080.3A patent/HK1244812A1/zh unknown
-
2019
- 2019-06-14 ZA ZA201903906A patent/ZA201903906B/en unknown
-
2020
- 2020-04-29 US US16/861,504 patent/US11447518B2/en active Active
- 2020-07-14 JP JP2020120896A patent/JP7046388B2/ja active Active
-
2021
- 2021-05-10 AU AU2021202967A patent/AU2021202967B2/en active Active
- 2021-08-02 US US17/391,586 patent/US11981699B2/en active Active
-
2022
- 2022-03-14 JP JP2022039571A patent/JP2022088451A/ja not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020183414A5 (ja) | ||
TWI758313B (zh) | 一種用於製備(1r,3r)-及(1s,3s)-2,2-二鹵基-3-(經取代之苯基)環丙烷甲酸的方法 | |
JP2014514262A (ja) | トレプロスチニル製造のための中間体の合成 | |
EP3221296B1 (en) | Method for the production of praziquantel and precursors thereof | |
JP6923805B2 (ja) | 含フッ素シクロプロパンカルボン酸類の製造方法 | |
JP2021503464A5 (ja) | レチノイドx受容体特異的なレチノイドの調製のための合成方法 | |
CN1882600A (zh) | 双磷杂环戊烷配体的制备方法 | |
CN1266148C (zh) | 制备2-吖丁啶酮衍生物的方法 | |
JP2011184318A (ja) | リボヌクレシドh−ボラノホスホネート | |
CN1045436C (zh) | 吡啶甲醇衍生物的制备方法 | |
CN105153257A (zh) | 索非布韦的制备方法 | |
CN1028994C (zh) | 1,3-双(三氟甲基)苯的锂化方法 | |
JP4195231B2 (ja) | 光学活性第2級ホスフィンボラン誘導体及びその中間体の製造方法 | |
CN1209116A (zh) | 制备酰肼类化合物的方法 | |
JP2000136193A (ja) | 光学活性ビスホスフィノメタン並びにそれらのロジウム又は銅錯体を用いる不斉合成 | |
JP2005298334A (ja) | 新規な中間体化合物およびそれを用いる化合物の製造方法 | |
CA2673076A1 (en) | Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates | |
CN102731572B (zh) | 含全氟烷基的膦配体、其制备方法、应用以及金属络合物 | |
IL272837B1 (en) | A process for preparing tubolysins and their intermediates | |
CN1388802A (zh) | 3-氨基-1-茚满醇、其合成方法和对映体的拆分 | |
KR101088488B1 (ko) | 광학활성을 갖는 암로디핀의 제조방법 | |
JP3855323B2 (ja) | 3−アミノ−2−オキソ−1−ハロゲノプロパン誘導体の製造方法 | |
JP2008143786A (ja) | 光学分割方法 | |
JP2002523479A (ja) | 銅触媒によるエナンチオ選択性アリル位置換反応 | |
JPH01100451A (ja) | 分離剤 |